Page last updated: 2024-10-31

nevirapine and Syndrome

nevirapine has been researched along with Syndrome in 9 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Syndrome: A characteristic symptom complex.

Research Excerpts

ExcerptRelevanceReference
"Drug rash with eosinophilia and systemic symptoms (DRESS Syndrome) associated with nevirapine treatment has not been previously reported in children."7.74Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. ( Barton, T; Ramilo, O; Santos, RP, 2007)
" We report the case of a pregnant human immunodeficiency virus type 1-infected woman who developed drug rash with eosinophilia and systemic symptoms syndrome and renal failure shortly after initiation of a nevirapine-containing antiretroviral regimen at 27 weeks' gestation."7.72Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus. ( Boswell, H; Fan-Havard, P; Knudtson, E; Para, M, 2003)
"Drug rash with eosinophilia and systemic symptoms (DRESS Syndrome) associated with nevirapine treatment has not been previously reported in children."3.74Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. ( Barton, T; Ramilo, O; Santos, RP, 2007)
" We report the case of a pregnant human immunodeficiency virus type 1-infected woman who developed drug rash with eosinophilia and systemic symptoms syndrome and renal failure shortly after initiation of a nevirapine-containing antiretroviral regimen at 27 weeks' gestation."3.72Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus. ( Boswell, H; Fan-Havard, P; Knudtson, E; Para, M, 2003)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's6 (66.67)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bayonne Kombo, ES1
Gathse, A1
Kochar, R1
Nevah, MI1
Lukens, FJ1
Fallon, MB1
Machicao, VI1
Bonnet, F1
Lawson-Ayayi, S1
Thiébaut, R1
Ramanampamonjy, R1
Lacoste, D1
Bernard, N1
Malvy, D1
Bonarek, M1
Djossou, F1
Beylot, J1
Dabis, F1
Morlat, P1
Knudtson, E1
Para, M1
Boswell, H1
Fan-Havard, P1
Daniel, OJ1
Krain, AB1
Ogun, SA1
Odusoga, OL1
Boyle, BA1
Santos, RP1
Ramilo, O1
Barton, T1
Martínez, E1
Gatell, JM1
Lanzafame, M1
Rovere, P1
De Checchi, G1
Trevenzoli, M1
Turazzini, M1
Parrinello, A1
Claudio, GA1
Martin, AF1
de Dios Perrino, S1
Velasco, AA1

Other Studies

9 other studies available for nevirapine and Syndrome

ArticleYear
[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Medecine et maladies infectieuses, 2013, Volume: 43, Issue:3

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asthenia; Benzoxazi

2013
Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.
    World journal of gastroenterology, 2010, Jul-14, Volume: 16, Issue:26

    Topics: Adult; Anti-HIV Agents; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cholestasis, Intrahepatic; Fem

2010
A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Nov-15, Volume: 35, Issue:10

    Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Cholesterol; Cohort Studies; Female; France; HIV Infec

2002
Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus.
    Obstetrics and gynecology, 2003, Volume: 101, Issue:5 Pt 2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injur

2003
Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
    Journal of the National Medical Association, 2005, Volume: 97, Issue:12

    Topics: Adult; Anti-HIV Agents; Drug Combinations; Exanthema; Female; HIV Infections; Humans; Nevirapine; Re

2005
Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:11

    Topics: Anti-HIV Agents; Child; Drug Hypersensitivity; Eosinophilia; Exanthema; Female; HIV Infections; HIV-

2007
[Lipodystrophy and antiretroviral agents].
    Revista clinica espanola, 1999, Volume: 199, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Prote

1999
Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.
    Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:6

    Topics: Adult; Anti-HIV Agents; Drug Eruptions; Drug Hypersensitivity; Eosinophilia; Exanthema; HIV Infectio

2001
DRESS syndrome associated with nevirapine therapy.
    Archives of internal medicine, 2001, Nov-12, Volume: 161, Issue:20

    Topics: Adult; Anti-HIV Agents; Drug Eruptions; Drug Monitoring; Eosinophilia; Fever; Humans; Liver Function

2001